Development of Cathepsin B‑Activatable Cell-Penetrating Peptides for Tumor Targeting.

Saved in:
Bibliographic Details
Title: Development of Cathepsin B‑Activatable Cell-Penetrating Peptides for Tumor Targeting.
Authors: Kuhne K; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, Dresden 01328, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Dresden 01069, Germany., Strohbach L; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, Dresden 01328, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Dresden 01069, Germany., Neuber C; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, Dresden 01328, Germany., Wodtke R; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, Dresden 01328, Germany., Ruiz-Gómez G; BIOTEC, Technische Universität Dresden, Tatzberg 47-49, Dresden 01307, Germany., Belter B; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, Dresden 01328, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Dresden 01069, Germany., Brandt F; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, Dresden 01328, Germany., Gluhacevic von Krüchten L; Institute of Pharmacy, Faculty of Chemistry and Pharmacy, Universität Regensburg, Universitätsstraße 31, Regensburg 93053, Germany., Keller M; Institute of Pharmacy, Faculty of Chemistry and Pharmacy, Universität Regensburg, Universitätsstraße 31, Regensburg 93053, Germany., Pisabarro MT; BIOTEC, Technische Universität Dresden, Tatzberg 47-49, Dresden 01307, Germany., Kopka K; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, Dresden 01328, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Dresden 01069, Germany., Pietzsch J; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, Dresden 01328, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Dresden 01069, Germany., Löser R; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, Dresden 01328, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Dresden 01069, Germany.
Source: ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2026 Feb 18; Vol. 9 (4), pp. 966-996. Date of Electronic Publication: 2026 Feb 18 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101721411 Publication Model: eCollection Cited Medium: Internet ISSN: 2575-9108 (Electronic) Linking ISSN: 25759108 NLM ISO Abbreviation: ACS Pharmacol Transl Sci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2575-9108
DOI:10.1021/acsptsci.5c00746